Predictive marker: Difference between revisions
CSV import |
CSV import |
||
| Line 47: | Line 47: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Revision as of 06:57, 11 February 2025
Predictive Marker
A predictive marker is a biomarker that is used to identify the likelihood of a patient's response to a particular treatment. These markers are often used in oncology to predict the effectiveness of certain chemotherapy drugs or radiation therapy.
Overview
Predictive markers are used to help determine the most effective treatment for a patient. They are often used in conjunction with other diagnostic tests and medical history to make a comprehensive treatment plan. Predictive markers can be found in the blood, tissue, or other bodily fluids and can be identified through various laboratory tests.
Types of Predictive Markers
There are several types of predictive markers used in medicine today. Some of the most common include:
- Genetic markers: These are changes in DNA that can predict a person's risk of developing certain diseases or their response to treatment.
- Protein markers: These are changes in the levels of certain proteins in the body that can indicate a disease or condition.
- Metabolic markers: These are changes in the body's metabolic processes that can indicate a disease or condition.
Use in Oncology
In oncology, predictive markers are often used to determine the most effective treatment for a patient. For example, the presence of the HER2 gene in breast cancer patients can predict a positive response to Herceptin, a targeted therapy drug. Similarly, the presence of the KRAS gene in colorectal cancer patients can predict a negative response to EGFR inhibitor drugs.
Future Directions
The field of predictive markers is constantly evolving, with new markers being discovered and validated regularly. The use of predictive markers in personalized medicine is a promising area of research, with the potential to greatly improve patient outcomes.
